Tag: Novartis Pharmaceuticals

Novartis Offers ScriptAssist Program for Exjade

March 10, 2009 – CAF would like to make patients aware of a new program offered by Novartis that may reduce your Exjade prescription copayments. This program –The Exjade ScriptAssist Program – provides an opportunity for patients to save up to $900 on their Exjade prescription copayments.   The Exjade ScriptAssist Program will run through May 31, […]

Read more

Label Change for Exjade

January 27, 2009 – In response to information concerning a label change for the iron chelator Exjade, CAF today forwarded the following letter to patients and health care providers:   We are writing to inform you that due to post-marketing reports of adverse effects, the FDA asked Novartis Pharmaceuticals to make a labeling change to […]

Read more

Secured By miniOrange